"","GO.cluster","IC","GO.ID","term","definition","Oral_elim.genes_frequency","Oral_elim.pvalue","Oral_elim.-log10_pvalue","Oral_elim.Significant_genes","Oral_elim.Significant_genes_symbol","Aboral_elim.genes_frequency","Aboral_elim.pvalue","Aboral_elim.-log10_pvalue","Aboral_elim.Significant_genes","Aboral_elim.Significant_genes_symbol","Cluster.name"
"1","1",8.23,"GO:0005308","creatine transmembrane transporter activity","Enables the transfer of creatine from one side of a membrane to the other. Creatine is a compound synthesized from the amino acids arginine, glycine, and methionine that occurs in muscle.","50% (4/8)",0.001958396,2.71,"Pocillopora_acuta_HIv2___RNAseq.g1200.t1;Pocillopora_acuta_HIv2___RNAseq.g26586.t1;Pocillopora_acuta_HIv2___TS.g16482.t1;Pocillopora_acuta_HIv2___TS.g16484.t1","Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13)","12.5% (1/8)",0.2558043,0.59,NA,NA,"Cluster 1: carboxylic acid transmembrane transporter activity"
"2","1",8.11,"GO:0005332","gamma-aminobutyric acid:sodium:chloride symporter activity","Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: gamma-aminobutyric acid(out) + Na+(out) + Cl-(out) = gamma-aminobutyric acid(in) + Na+(in) + Cl(in).","44.444% (4/9)",0.003309641,2.48,"Pocillopora_acuta_HIv2___RNAseq.g1200.t1;Pocillopora_acuta_HIv2___RNAseq.g28251.t1;Pocillopora_acuta_HIv2___TS.g16482.t1;Pocillopora_acuta_HIv2___TS.g16484.t1","Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13)","11.111% (1/9)",0.2828005,0.55,NA,NA,"Cluster 1: carboxylic acid transmembrane transporter activity"
"3","1",7.82,"GO:0033229","cysteine transmembrane transporter activity","Enables the transfer of cysteine from one side of a membrane to the other.","41.667% (5/12)",0.001389783,2.86,"Pocillopora_acuta_HIv2___RNAseq.g12410.t1;Pocillopora_acuta_HIv2___RNAseq.g22644.t1;Pocillopora_acuta_HIv2___RNAseq.g7215.t1;Pocillopora_acuta_HIv2___RNAseq.g7217.t1;Pocillopora_acuta_HIv2___TS.g22105.t1","Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2);Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1);Major facilitator superfamily domain-containing protein 12 (Protein grizzled);Major facilitator superfamily domain-containing protein 12 (Protein grizzled);Major facilitator superfamily domain-containing protein 12","0% (0/12)",1,0,NA,NA,"Cluster 1: carboxylic acid transmembrane transporter activity"
"4","1",8.7,"GO:0000064","L-ornithine transmembrane transporter activity","Enables the transfer of L-ornithine from one side of a membrane to the other. L-ornithine is 2,5-diaminopentanoic acid.","60% (3/5)",0.004139208,2.38,"Pocillopora_acuta_HIv2___RNAseq.25384_t;Pocillopora_acuta_HIv2___RNAseq.g19152.t1;Pocillopora_acuta_HIv2___TS.g5171.t1","Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2);High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter);Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)","0% (0/5)",1,0,NA,NA,"Cluster 1: carboxylic acid transmembrane transporter activity"
"5","1",8.51,"GO:0015189","L-lysine transmembrane transporter activity","Enables the transfer of L-lysine from one side of a membrane to the other. L-lysine is 2,6-diaminohexanoic acid.","66.667% (4/6)",0.0004763373,3.32,"Pocillopora_acuta_HIv2___RNAseq.25384_t;Pocillopora_acuta_HIv2___RNAseq.g19152.t1;Pocillopora_acuta_HIv2___RNAseq.g25241.t1;Pocillopora_acuta_HIv2___TS.g5171.t1","Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2);High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter);Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29);Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)","0% (0/6)",1,0,NA,NA,"Cluster 1: carboxylic acid transmembrane transporter activity"
"6","1",8.51,"GO:0061459","L-arginine transmembrane transporter activity","Enables the transfer of L-arginine from one side of a membrane to the other.","66.667% (4/6)",0.0004763373,3.32,"Pocillopora_acuta_HIv2___RNAseq.25384_t;Pocillopora_acuta_HIv2___RNAseq.g19152.t1;Pocillopora_acuta_HIv2___RNAseq.g25241.t1;Pocillopora_acuta_HIv2___TS.g5171.t1","Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2);High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter);Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29);Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)","0% (0/6)",1,0,NA,NA,"Cluster 1: carboxylic acid transmembrane transporter activity"
"7","2",5.42,"GO:0015085","calcium ion transmembrane transporter activity","Enables the transfer of calcium (Ca) ions from one side of a membrane to the other.","15.957% (15/94)",0.00560731,2.25,"Pocillopora_acuta_HIv2___RNAseq.10010_t;Pocillopora_acuta_HIv2___RNAseq.g11916.t1;Pocillopora_acuta_HIv2___RNAseq.g12898.t1;Pocillopora_acuta_HIv2___RNAseq.g18121.t1;Pocillopora_acuta_HIv2___RNAseq.g23883.t2;Pocillopora_acuta_HIv2___RNAseq.g24761.t1;Pocillopora_acuta_HIv2___RNAseq.g26118.t1;Pocillopora_acuta_HIv2___RNAseq.g27978.t1;Pocillopora_acuta_HIv2___RNAseq.g29670.t2;Pocillopora_acuta_HIv2___RNAseq.g5755.t1;Pocillopora_acuta_HIv2___RNAseq.g701.t1;Pocillopora_acuta_HIv2___RNAseq.g702.t1;Pocillopora_acuta_HIv2___RNAseq.g9466.t1;Pocillopora_acuta_HIv2___TS.g14960.t2;Pocillopora_acuta_HIv2___TS.g21857.t1","Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor);Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10);Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4);Sodium/calcium exchanger NCL2 (Na(+)/Ca(2+)-exchange protein NCL2) (OsEFCAX2) (Protein NCX-like 2) (OsNCL2);VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1);Annexin A6 (Annexin VI) (Annexin-6);Voltage-dependent calcium channel type A subunit alpha-1 (Cacophony protein);Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4);Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3);Short transient receptor potential channel 5 (TrpC5) (Capacitative calcium entry channel 2) (CCE2) (Transient receptor protein 5) (TRP-5) (mTRP5) (Trp-related protein 5);Polycystin-2 (Polycystic kidney disease 2 protein homolog);Sperm receptor for egg jelly (suREJ);Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor);Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6);Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3)","0% (0/94)",1,0,NA,NA,"Cluster 2: transmembrane transporter activity"
"8","2",5.49,"GO:0005267","potassium channel activity","Enables the energy-independent facilitated diffusion of a potassium ion through a transmembrane aqueous pore or channel.","17.391% (12/69)",0.00633196,2.2,"Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g15097.t1;Pocillopora_acuta_HIv2___RNAseq.g17559.t1;Pocillopora_acuta_HIv2___RNAseq.g17622.t1;Pocillopora_acuta_HIv2___RNAseq.g18617.t1;Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g29275.t1;Pocillopora_acuta_HIv2___RNAseq.g4469.t1;Pocillopora_acuta_HIv2___RNAseq.g6094.t2;Pocillopora_acuta_HIv2___RNAseq.g701.t1;Pocillopora_acuta_HIv2___TS.g14960.t2;Pocillopora_acuta_HIv2___TS.g26021.t1","Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Potassium voltage-gated channel subfamily A member 10 (Voltage-gated potassium channel subunit Kv1.8);TWiK family of potassium channels protein 7;Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln));Putative potassium channel protein YugO;Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2);Endosomal/lysosomal proton channel TMEM175 (Potassium channel TMEM175) (Transmembrane protein 175);Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (hSlo);Polycystin-2 (Polycystic kidney disease 2 protein homolog);Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6);Putative potassium channel protein YugO","1.449% (1/69)",0.9224637,0.04,NA,NA,"Cluster 2: transmembrane transporter activity"
"9","2",6.94,"GO:1904315","transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential",NA,"30.435% (7/23)",0.001343999,2.87,"Pocillopora_acuta_HIv2___RNAseq.g11916.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g26672.t1;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___RNAseq.g28202.t1;Pocillopora_acuta_HIv2___RNAseq.g28741.t1;Pocillopora_acuta_HIv2___TS.g14960.t2","Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Neuronal acetylcholine receptor subunit alpha-7 (nAChR7) (Nicotinic acetylcholine receptor subunit alpha-7);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Neuronal acetylcholine receptor subunit beta-3;Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6)","0% (0/23)",1,0,NA,NA,"Cluster 2: transmembrane transporter activity"
"10","2",3.99,"GO:0015267","channel activity","Enables the energy-independent facilitated diffusion of a solute through a transmembrane aqueous pore or channel. Stereospecificity is not exhibited but this transport may be specific for a particular molecular species or class of molecules.","16.206% (41/253)",0.008320683,2.08,"Pocillopora_acuta_HIv2___RNAseq.10010_t;Pocillopora_acuta_HIv2___RNAseq.18284_t;Pocillopora_acuta_HIv2___RNAseq.g11916.t1;Pocillopora_acuta_HIv2___RNAseq.g12898.t1;Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g15097.t1;Pocillopora_acuta_HIv2___RNAseq.g16474.t1;Pocillopora_acuta_HIv2___RNAseq.g17559.t1;Pocillopora_acuta_HIv2___RNAseq.g17622.t1;Pocillopora_acuta_HIv2___RNAseq.g18059.t1;Pocillopora_acuta_HIv2___RNAseq.g18617.t1;Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g19042.t1;Pocillopora_acuta_HIv2___RNAseq.g19043.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g2273.t1;Pocillopora_acuta_HIv2___RNAseq.g23883.t2;Pocillopora_acuta_HIv2___RNAseq.g24029.t1;Pocillopora_acuta_HIv2___RNAseq.g24761.t1;Pocillopora_acuta_HIv2___RNAseq.g26118.t1;Pocillopora_acuta_HIv2___RNAseq.g26672.t1;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___RNAseq.g28202.t1;Pocillopora_acuta_HIv2___RNAseq.g28270.t1;Pocillopora_acuta_HIv2___RNAseq.g28741.t1;Pocillopora_acuta_HIv2___RNAseq.g29275.t1;Pocillopora_acuta_HIv2___RNAseq.g29670.t2;Pocillopora_acuta_HIv2___RNAseq.g3666.t1a;Pocillopora_acuta_HIv2___RNAseq.g4469.t1;Pocillopora_acuta_HIv2___RNAseq.g5755.t1;Pocillopora_acuta_HIv2___RNAseq.g6094.t2;Pocillopora_acuta_HIv2___RNAseq.g701.t1;Pocillopora_acuta_HIv2___RNAseq.g702.t1;Pocillopora_acuta_HIv2___RNAseq.g9466.t1;Pocillopora_acuta_HIv2___TS.g14960.t2;Pocillopora_acuta_HIv2___TS.g15134.t1;Pocillopora_acuta_HIv2___TS.g16172.t3;Pocillopora_acuta_HIv2___TS.g19790.t1;Pocillopora_acuta_HIv2___TS.g21128.t1;Pocillopora_acuta_HIv2___TS.g21857.t1;Pocillopora_acuta_HIv2___TS.g26021.t1","Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor);Putative ammonium transporter 3;Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10);Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4);Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Potassium voltage-gated channel subfamily A member 10 (Voltage-gated potassium channel subunit Kv1.8);Solute carrier family 12 member 2 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (NKCC1) (Na-K-CL symporter);TWiK family of potassium channels protein 7;Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln));Aquaporin AQPAe.a;Putative potassium channel protein YugO;Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G);Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Putative ammonium transporter 1;VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1);Epithelial sodium channel subunit alpha (Alpha-ENaC) (Epithelial Na(+) channel subunit alpha) (Alpha-NaCH) (Amiloride-sensitive sodium channel subunit alpha) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA);Annexin A6 (Annexin VI) (Annexin-6);Voltage-dependent calcium channel type A subunit alpha-1 (Cacophony protein);Neuronal acetylcholine receptor subunit alpha-7 (nAChR7) (Nicotinic acetylcholine receptor subunit alpha-7);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Neuronal acetylcholine receptor subunit beta-3;Bcl-2 homologous antagonist/killer (Apoptosis regulator BAK);Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2);Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3);Major facilitator superfamily domain-containing protein 8;Endosomal/lysosomal proton channel TMEM175 (Potassium channel TMEM175) (Transmembrane protein 175);Short transient receptor potential channel 5 (TrpC5) (Capacitative calcium entry channel 2) (CCE2) (Transient receptor protein 5) (TRP-5) (mTRP5) (Trp-related protein 5);Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (hSlo);Polycystin-2 (Polycystic kidney disease 2 protein homolog);Sperm receptor for egg jelly (suREJ);Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor);Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6);Mechanosensory protein 2;Sodium channel protein 1 brain (Sodium channel protein I brain);Chloride intracellular channel protein 3 (Glutaredoxin-like oxidoreductase CLIC3) (EC 1.8.-.-);Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b);Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3);Putative potassium channel protein YugO","0.791% (2/253)",0.9991708,0,NA,NA,"Cluster 2: transmembrane transporter activity"
"11","2",6.59,"GO:0005254","chloride channel activity","Enables the energy-independent facilitated diffusion of a chloride ion through a transmembrane aqueous pore or channel.","25.806% (8/31)",0.002008129,2.7,"Pocillopora_acuta_HIv2___RNAseq.g17622.t1;Pocillopora_acuta_HIv2___RNAseq.g19042.t1;Pocillopora_acuta_HIv2___RNAseq.g19043.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___RNAseq.g28741.t1;Pocillopora_acuta_HIv2___RNAseq.g3666.t1a;Pocillopora_acuta_HIv2___TS.g19790.t1","Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln));Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G);Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);Major facilitator superfamily domain-containing protein 8;Chloride intracellular channel protein 3 (Glutaredoxin-like oxidoreductase CLIC3) (EC 1.8.-.-)","0% (0/31)",1,0,NA,NA,"Cluster 2: transmembrane transporter activity"
"12","2",7.42,"GO:0099095","ligand-gated monoatomic anion channel activity","Enables the transmembrane transfer of an inorganic anion by a channel that opens when a specific ligand has been bound by the channel complex or one of its constituent parts.","35.294% (6/17)",0.001261704,2.9,"Pocillopora_acuta_HIv2___RNAseq.g17622.t1;Pocillopora_acuta_HIv2___RNAseq.g19042.t1;Pocillopora_acuta_HIv2___RNAseq.g19043.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___RNAseq.g28741.t1","Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln));Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G);Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit)","0% (0/17)",1,0,NA,NA,"Cluster 2: transmembrane transporter activity"
"13","3",6.69,"GO:0005125","cytokine activity","The activity of a soluble extracellular gene product that interacts with a receptor to effect a change in the activity of the receptor to control the survival, growth, differentiation and effector function of tissues and cells.","10.811% (4/37)",0.3229546,0.49,NA,NA,"24.324% (9/37)",4.905801e-06,5.31,"Pocillopora_acuta_HIv2___RNAseq.7335_t;Pocillopora_acuta_HIv2___RNAseq.g12378.t1;Pocillopora_acuta_HIv2___RNAseq.g13857.t1;Pocillopora_acuta_HIv2___RNAseq.g20144.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1","Nodal homolog (Nodal-related protein 1) (Xnr-1) (Xnr1) (nr-1);Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1) (TIMP-1);Bone morphogenetic protein 2 (BMP-2);Growth/differentiation factor 6 (GDF-6) (Bone morphogenetic protein 13) (BMP-13) (Growth/differentiation factor 16);Protein Wnt-7a;Protein Wnt-8b;Protein Wnt-8a;Protein Wnt-8b;Protein Wnt-8b","Cluster 3: protein binding"
"14","3",5.69,"GO:0048018","receptor ligand activity","The activity of a gene product that interacts with a receptor to effect a change in the activity of the receptor. Ligands may be produced by the same cell that expresses the receptor. Ligands may also be expressed at the plasma membrane of an adjacent cell (e.g. Notch ligands) or be secreted and diffuse extracellularly from their point of origin to the receiving cell (e.g. interleukins).","8.861% (7/79)",0.4161052,0.38,NA,NA,"20.253% (16/79)",0.001565302,2.81,"Pocillopora_acuta_HIv2___RNAseq.7335_t;Pocillopora_acuta_HIv2___RNAseq.g12378.t1;Pocillopora_acuta_HIv2___RNAseq.g13857.t1;Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g20144.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___TS.g1462.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b","Nodal homolog (Nodal-related protein 1) (Xnr-1) (Xnr1) (nr-1);Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1) (TIMP-1);Bone morphogenetic protein 2 (BMP-2);Fibrillin-2 [Cleaved into: Placensin];Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Growth/differentiation factor 6 (GDF-6) (Bone morphogenetic protein 13) (BMP-13) (Growth/differentiation factor 16);Protein Wnt-7a;Protein Wnt-8b;Protein Wnt-8a;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Protein jagged-1 (Jagged1) (CD antigen CD339);Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b (Complement C3b-alpha' chain); Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];Fibrillin-1 (MP340) [Cleaved into: Asprosin];Protein Wnt-8b;Protein Wnt-8b;Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]","Cluster 3: protein binding"
"15","3",6.9,"GO:0008083","growth factor activity","The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.","6.667% (2/30)",0.6885152,0.16,NA,NA,"20% (6/30)",0.0006152321,3.21,"Pocillopora_acuta_HIv2___RNAseq.7335_t;Pocillopora_acuta_HIv2___RNAseq.g12378.t1;Pocillopora_acuta_HIv2___RNAseq.g13857.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g20144.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1","Nodal homolog (Nodal-related protein 1) (Xnr-1) (Xnr1) (nr-1);Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1) (TIMP-1);Bone morphogenetic protein 2 (BMP-2);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Growth/differentiation factor 6 (GDF-6) (Bone morphogenetic protein 13) (BMP-13) (Growth/differentiation factor 16);Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339)","Cluster 3: protein binding"
"16","3",7.91,"GO:0005158","insulin receptor binding","Binding to an insulin receptor.","36.364% (4/11)",0.007645086,2.12,"Pocillopora_acuta_HIv2___RNAseq.g12287.t1;Pocillopora_acuta_HIv2___RNAseq.g12289.t1;Pocillopora_acuta_HIv2___RNAseq.g9334.t1;Pocillopora_acuta_HIv2___TS.g1768.t1","Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)","0% (0/11)",1,0,NA,NA,"Cluster 3: protein binding"
"17","3",6.78,"GO:0005109","frizzled binding","Binding to a frizzled (fz) receptor.","11.765% (4/34)",0.2691767,0.57,NA,NA,"17.647% (6/34)",0.001233435,2.91,"Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1","Collagen triple helix repeat-containing protein 1;Protein Wnt-7a;Protein Wnt-8b;Protein Wnt-8a;Protein Wnt-8b;Protein Wnt-8b","Cluster 3: protein binding"
"18","3",8,"GO:0045545","syndecan binding","Binding to syndecan, an integral membrane proteoglycan (250-300 kDa) associated largely with epithelial cells.","10% (1/10)",0.5545711,0.26,NA,NA,"30% (3/10)",0.004682527,2.33,"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1","Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)","Cluster 3: protein binding"
"19","3",6.94,"GO:0043394","proteoglycan binding","Binding to a proteoglycan, any glycoprotein in which the carbohydrate units are glycosaminoglycans.","4% (1/25)",0.8678123,0.06,NA,NA,"28% (7/25)",0.001634758,2.79,"Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g26979.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b","Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain];Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]","Cluster 3: protein binding"
"20","3",8.36,"GO:0048407","platelet-derived growth factor binding","Binding to platelet-derived growth factor.","0% (0/7)",1,0,NA,NA,"71.429% (5/7)",1.20064e-06,5.92,"Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1","Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen)","Cluster 3: protein binding"
"21","3",7.01,"GO:0019894","kinesin binding","Interacting selectively and non-covalently and stoichiometrically with kinesin, a member of a superfamily of microtubule-based motor proteins that perform force-generating tasks such as organelle transport and chromosome segregation.","25.926% (7/27)",0.003705887,2.43,"Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g14867.t1;Pocillopora_acuta_HIv2___RNAseq.g14868.t1b;Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g30425.t2;Pocillopora_acuta_HIv2___RNAseq.g4399.t2;Pocillopora_acuta_HIv2___TS.g20127.t1b","Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Kinesin light chain 4 (KLC 4) (Kinesin-like protein 8);Kinesin light chain (KLC);Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);Rootletin (Ciliary rootlet coiled-coil protein);Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2);Kinesin light chain 4 (KLC 4) (Kinesin-like protein 8)","0% (0/27)",1,0,NA,NA,"Cluster 3: protein binding"
"22","3",6.62,"GO:0017147","Wnt-protein binding","Binding to a Wnt-protein, a secreted growth factor involved in signaling.","12.5% (5/40)",0.1959672,0.71,NA,NA,"15% (6/40)",0.002933357,2.53,"Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g2565.t1;Pocillopora_acuta_HIv2___RNAseq.g26050.t1;Pocillopora_acuta_HIv2___RNAseq.g434.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1","Collagen triple helix repeat-containing protein 1;Secreted frizzled-related protein 5 (sFRP-5);Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1);Frizzled-5 (Fz-5) (Xfz5);Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5)","Cluster 3: protein binding"
"23","4",4.7,"GO:0000978","RNA polymerase II cis-regulatory region sequence-specific DNA binding","Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II.","12.075% (32/265)",0.008013487,2.1,"Pocillopora_acuta_HIv2___RNAseq.26564_t;Pocillopora_acuta_HIv2___RNAseq.665_t;Pocillopora_acuta_HIv2___RNAseq.g10180.t1;Pocillopora_acuta_HIv2___RNAseq.g10408.t1;Pocillopora_acuta_HIv2___RNAseq.g11673.t1;Pocillopora_acuta_HIv2___RNAseq.g14060.t1;Pocillopora_acuta_HIv2___RNAseq.g16957.t1;Pocillopora_acuta_HIv2___RNAseq.g1930.t1;Pocillopora_acuta_HIv2___RNAseq.g1932.t1;Pocillopora_acuta_HIv2___RNAseq.g22722.t1;Pocillopora_acuta_HIv2___RNAseq.g22749.t1;Pocillopora_acuta_HIv2___RNAseq.g25327.t1;Pocillopora_acuta_HIv2___RNAseq.g25686.t1;Pocillopora_acuta_HIv2___RNAseq.g25869.t1;Pocillopora_acuta_HIv2___RNAseq.g27673.t1;Pocillopora_acuta_HIv2___RNAseq.g28639.t1;Pocillopora_acuta_HIv2___RNAseq.g29836.t1;Pocillopora_acuta_HIv2___RNAseq.g2995.t1;Pocillopora_acuta_HIv2___RNAseq.g30663.t1;Pocillopora_acuta_HIv2___RNAseq.g31038.t1;Pocillopora_acuta_HIv2___RNAseq.g3322.t1;Pocillopora_acuta_HIv2___RNAseq.g3837.t1a;Pocillopora_acuta_HIv2___RNAseq.g439.t1;Pocillopora_acuta_HIv2___RNAseq.g7803.t1;Pocillopora_acuta_HIv2___RNAseq.g8093.t1;Pocillopora_acuta_HIv2___RNAseq.g8690.t1;Pocillopora_acuta_HIv2___RNAseq.g8876.t1;Pocillopora_acuta_HIv2___TS.g11075.t2;Pocillopora_acuta_HIv2___TS.g19999.t1;Pocillopora_acuta_HIv2___TS.g21030.t2;Pocillopora_acuta_HIv2___TS.g23568.t2d;Pocillopora_acuta_HIv2___TS.g4588.t1","Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2);POU domain, class 4, transcription factor 3 (Brain-specific homeobox/POU domain protein 3C) (Brain-3C) (Brn-3C);Homeobox protein Nkx-2.5 (xNKx-2.5) (Homeobox protein NK-2 homolog E);Nuclear transcription factor Y subunit alpha (CAAT box DNA-binding protein subunit A) (Nuclear transcription factor Y subunit A) (NF-YA);POU domain, class 3, transcription factor 2-B (Transcription factor POU3-B) (XlPOU3B);Insulinoma-associated protein 1 (Zinc finger protein IA-1);Transcription factor SOX-4;Transcriptional regulator Myc-A (c-Myc-A) (zc-Myc);Protein S-Myc;Transcription factor ovo-like homolog lin-48 (Abnormal cell lineage protein 48);Transcription factor Sox-3;Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2);Transcription factor Sox-14;DNA-binding protein RFX6 (Regulatory factor X 6);Paired box protein Pax-6 (Oculorhombin);DNA-binding protein RFX7 (Regulatory factor X 7);Circadian locomoter output cycles protein kaput;Transcription factor HES-4-A (Hairy and enhancer of split 4-A) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2a);Cellular tumor antigen p53 (Tumor suppressor p53);ETS translocation variant 1 (Ets-related protein 81);Homeobox protein Dlx4a (DLX-8) (Distal-less homeobox protein 4a);Paired box protein Pax-2a (No isthmus protein) (Pax[Zf-b]);N-glycosylase/DNA lyase [Includes: 8-oxoguanine DNA glycosylase (EC 3.2.2.-); DNA-(apurinic or apyrimidinic site) lyase (AP lyase) (EC 4.2.99.18)];Transcription factor sox-2;Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.-) (ATP-dependent helicase CHD7);Forkhead box protein L2;Homeobox protein not2 (Xnot-2) (Xnot2);Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13);Retinal homeobox protein Rx2;Doublesex- and mab-3-related transcription factor A2 (Doublesex- and mab-3-related transcription factor 5);DNA-binding protein P3A2;Transcription factor Sp5","4.906% (13/265)",0.1655205,0.78,NA,NA,"Cluster 4: binding"
"24","4",6.64,"GO:0035198","miRNA binding","Binding to a microRNA, a 21-23 nucleotide RNA that is processed from a stem-loop RNA precursor (pre-miRNA) that is encoded within plant and animal genomes.","23.077% (9/39)",0.002482371,2.61,"Pocillopora_acuta_HIv2___RNAseq.g13082.t1;Pocillopora_acuta_HIv2___RNAseq.g16905.t1;Pocillopora_acuta_HIv2___RNAseq.g16957.t1;Pocillopora_acuta_HIv2___RNAseq.g1800.t1;Pocillopora_acuta_HIv2___RNAseq.g24787.t1;Pocillopora_acuta_HIv2___RNAseq.g24800.t1;Pocillopora_acuta_HIv2___RNAseq.g28169.t1;Pocillopora_acuta_HIv2___RNAseq.g4128.t2;Pocillopora_acuta_HIv2___RNAseq.g4938.t1","28S rRNA (uridine-N(3))-methyltransferase (EC 2.1.1.-) (Centromere protein 32) (CENP-32) (Kinetochore-associated protein) (Methyltransferase C9orf114) (Ribosomal RNA methyltransferase SPOUT1) (SPOUT domain-containing methyltransferase 1);E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71);Transcription factor SOX-4;E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71);E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71);E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71);E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71);Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11);E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","0% (0/39)",1,0,NA,NA,"Cluster 4: binding"
"25","4",7.36,"GO:0009374","biotin binding","Binding to biotin (cis-tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid), the (+) enantiomer of which is very widely distributed in cells and serves as a carrier in a number of enzymatic beta-carboxylation reactions.","42.105% (8/19)",4.437452e-05,4.35,"Pocillopora_acuta_HIv2___RNAseq.g28227.t1;Pocillopora_acuta_HIv2___RNAseq.g3222.t1;Pocillopora_acuta_HIv2___RNAseq.g8913.t1;Pocillopora_acuta_HIv2___RNAseq.g8915.t1;Pocillopora_acuta_HIv2___TS.g1731.t1;Pocillopora_acuta_HIv2___TS.g19499.t2;Pocillopora_acuta_HIv2___TS.g23115.t1;Pocillopora_acuta_HIv2___TS.g9749.t1","Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","5.263% (1/19)",0.5044709,0.3,NA,NA,"Cluster 4: binding"
"26","4",3.99,"GO:0005509","calcium ion binding","Binding to a calcium ion (Ca2+).","15.495% (86/555)",1.947152e-10,9.71,"Pocillopora_acuta_HIv2___RNAseq.30415_t;Pocillopora_acuta_HIv2___RNAseq.6093_tb;Pocillopora_acuta_HIv2___RNAseq.g10475.t1;Pocillopora_acuta_HIv2___RNAseq.g11580.t1;Pocillopora_acuta_HIv2___RNAseq.g11588.t1;Pocillopora_acuta_HIv2___RNAseq.g12286.t1;Pocillopora_acuta_HIv2___RNAseq.g12290.t1;Pocillopora_acuta_HIv2___RNAseq.g12292.t1;Pocillopora_acuta_HIv2___RNAseq.g12617.t1;Pocillopora_acuta_HIv2___RNAseq.g13576.t1;Pocillopora_acuta_HIv2___RNAseq.g13977.t1;Pocillopora_acuta_HIv2___RNAseq.g14640.t1;Pocillopora_acuta_HIv2___RNAseq.g14871.t1;Pocillopora_acuta_HIv2___RNAseq.g15159.t1;Pocillopora_acuta_HIv2___RNAseq.g15567.t1;Pocillopora_acuta_HIv2___RNAseq.g15816.t1;Pocillopora_acuta_HIv2___RNAseq.g16486.t1;Pocillopora_acuta_HIv2___RNAseq.g16948.t1;Pocillopora_acuta_HIv2___RNAseq.g18121.t1;Pocillopora_acuta_HIv2___RNAseq.g18214.t1;Pocillopora_acuta_HIv2___RNAseq.g19312.t1;Pocillopora_acuta_HIv2___RNAseq.g19392.t1;Pocillopora_acuta_HIv2___RNAseq.g19600.t1;Pocillopora_acuta_HIv2___RNAseq.g20232.t1;Pocillopora_acuta_HIv2___RNAseq.g2384.t1;Pocillopora_acuta_HIv2___RNAseq.g24120.t1;Pocillopora_acuta_HIv2___RNAseq.g24760.t1;Pocillopora_acuta_HIv2___RNAseq.g24761.t1;Pocillopora_acuta_HIv2___RNAseq.g25003.t1;Pocillopora_acuta_HIv2___RNAseq.g25934.t1;Pocillopora_acuta_HIv2___RNAseq.g26118.t1;Pocillopora_acuta_HIv2___RNAseq.g26596.t1;Pocillopora_acuta_HIv2___RNAseq.g26613.t1;Pocillopora_acuta_HIv2___RNAseq.g26782.t1;Pocillopora_acuta_HIv2___RNAseq.g27399.t1;Pocillopora_acuta_HIv2___RNAseq.g28025.t1;Pocillopora_acuta_HIv2___RNAseq.g2813.t4;Pocillopora_acuta_HIv2___RNAseq.g28227.t1;Pocillopora_acuta_HIv2___RNAseq.g2827.t1;Pocillopora_acuta_HIv2___RNAseq.g28815.t1;Pocillopora_acuta_HIv2___RNAseq.g28858.t1;Pocillopora_acuta_HIv2___RNAseq.g2915.t1;Pocillopora_acuta_HIv2___RNAseq.g29841.t1;Pocillopora_acuta_HIv2___RNAseq.g3016.t1;Pocillopora_acuta_HIv2___RNAseq.g3051.t1;Pocillopora_acuta_HIv2___RNAseq.g30904.t1;Pocillopora_acuta_HIv2___RNAseq.g3222.t1;Pocillopora_acuta_HIv2___RNAseq.g3532.t1;Pocillopora_acuta_HIv2___RNAseq.g3746.t1;Pocillopora_acuta_HIv2___RNAseq.g4028.t1;Pocillopora_acuta_HIv2___RNAseq.g4031.t1c;Pocillopora_acuta_HIv2___RNAseq.g4369.t1;Pocillopora_acuta_HIv2___RNAseq.g4399.t2;Pocillopora_acuta_HIv2___RNAseq.g4732.t1;Pocillopora_acuta_HIv2___RNAseq.g6366.t1;Pocillopora_acuta_HIv2___RNAseq.g701.t1;Pocillopora_acuta_HIv2___RNAseq.g702.t1;Pocillopora_acuta_HIv2___RNAseq.g710.t1;Pocillopora_acuta_HIv2___RNAseq.g7553.t1;Pocillopora_acuta_HIv2___RNAseq.g8520.t1;Pocillopora_acuta_HIv2___RNAseq.g8644.t1;Pocillopora_acuta_HIv2___RNAseq.g8913.t1;Pocillopora_acuta_HIv2___RNAseq.g8915.t1;Pocillopora_acuta_HIv2___TS.g14552.t1;Pocillopora_acuta_HIv2___TS.g14962.t1;Pocillopora_acuta_HIv2___TS.g1731.t1;Pocillopora_acuta_HIv2___TS.g19499.t2;Pocillopora_acuta_HIv2___TS.g20007.t1;Pocillopora_acuta_HIv2___TS.g20880.t1;Pocillopora_acuta_HIv2___TS.g21616.t3a;Pocillopora_acuta_HIv2___TS.g22704.t2;Pocillopora_acuta_HIv2___TS.g23115.t1;Pocillopora_acuta_HIv2___TS.g23175.t1;Pocillopora_acuta_HIv2___TS.g24807.t1;Pocillopora_acuta_HIv2___TS.g25258.t1;Pocillopora_acuta_HIv2___TS.g25259.t2;Pocillopora_acuta_HIv2___TS.g29407.t1;Pocillopora_acuta_HIv2___TS.g3024.t4;Pocillopora_acuta_HIv2___TS.g3256.t1;Pocillopora_acuta_HIv2___TS.g6578.t1;Pocillopora_acuta_HIv2___TS.g7149.t2;Pocillopora_acuta_HIv2___TS.g9126.t1;Pocillopora_acuta_HIv2___TS.g9414.t1;Pocillopora_acuta_HIv2___TS.g9749.t1;Pocillopora_acuta_HIv2___TS.g9752.t3;Pocillopora_acuta_HIv2___TS.g9777.t1","Synaptotagmin-10 (Synaptotagmin X) (SytX);Multiple coagulation factor deficiency protein 2 homolog (Neural stem cell-derived neuronal survival protein);Myoferlin (Fer-1-like protein 3);Hemicentin-1 (Fibulin-6) (FIBL-6);Mucin-like protein;Fucolectin-4;Fucolectin;Fucolectin;Calcium-binding mitochondrial carrier protein (Mitochondrial substrate carrier family protein O);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);Mucin-like protein;Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein);Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR);Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2);Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain);Nucleoside hydrolase (EC 3.2.2.-) (EC 3.2.2.1) (EC 3.2.2.2) (EC 3.2.2.3) (EC 3.2.2.7) (EC 3.2.2.8);Mucin-like protein;Neurocalcin homolog (DrosNCa);Sodium/calcium exchanger NCL2 (Na(+)/Ca(2+)-exchange protein NCL2) (OsEFCAX2) (Protein NCX-like 2) (OsNCL2);Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13);1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2);Calcyphosin-like protein;Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1);Calmodulin, striated muscle;Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)];Annexin A6 (Annexin VI) (Annexin-6);Mucin-like protein;Fibrillin-1 [Cleaved into: Asprosin];Voltage-dependent calcium channel type A subunit alpha-1 (Cacophony protein);Hemicentin-2;Calcyphosin-2 (Calcyphosine-2);Tolloid-like protein 1 (EC 3.4.24.-) (Chicken tolloid-like protein 1) (Metalloprotease colloid);Tolloid-like protein 2 (EC 3.4.24.-) (Metalloprotease xolloid) (Xenopus tolloid);Cubilin (Intrinsic factor-cobalamin receptor);EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated channel regulator 2A) (Ras-related protein Rab-46) (EC 3.6.5.2);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synaptotagmin-1 (Synaptotagmin I) (SytI);Collectin-11 (Collectin kidney protein 1) (CL-K1);Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2);Matrilin-2;Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I);Villin-1;Calmodulin-2 (CaM-2);Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III);Myosin regulatory light polypeptide 9 (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9);Hippocalcin-like protein 1 (Calcium-binding protein BDR-1) (HLP2) (Visinin-like protein 3) (VILIP-3);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synaptotagmin-1 (Synaptotagmin I) (SytI);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2);Calmodulin (CaM);Adhesion G protein-coupled receptor L4;Polycystin-2 (Polycystic kidney disease 2 protein homolog);Sperm receptor for egg jelly (suREJ);Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2);Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form];Hemicentin-1 (Fibulin-6) (FIBL-6);Calmodulin (CaM);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Cadherin-23 (Otocadherin);Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III);Thrombospondin-3;Cell growth regulator with EF hand domain protein 1 (Cell growth regulatory gene 11 protein) (Hydrophobestin);Calmodulin (CaM);Calmodulin-like protein 3;Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Mucin-like protein;Mucin-like protein;Matrilin-2;Protein unc-13 homolog C (Munc13-3);Fucolectin-3;Protocadherin-like protein;Ciliary-associated calcium-binding coiled-coil protein 1;E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B);Follistatin-related protein 5 (Follistatin-like protein 5) (m-D/Bsp120I 1-2);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form];Oncoprotein-induced transcript 3 protein","11.712% (65/555)",7.713114e-18,17.11,"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.21012_t;Pocillopora_acuta_HIv2___RNAseq.21015_t;Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.820_t;Pocillopora_acuta_HIv2___RNAseq.g10343.t1;Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g1127.t2;Pocillopora_acuta_HIv2___RNAseq.g11876.t1;Pocillopora_acuta_HIv2___RNAseq.g12987.t1;Pocillopora_acuta_HIv2___RNAseq.g13823.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g15698.t1;Pocillopora_acuta_HIv2___RNAseq.g15699.t1;Pocillopora_acuta_HIv2___RNAseq.g1638.t1;Pocillopora_acuta_HIv2___RNAseq.g16484.t1;Pocillopora_acuta_HIv2___RNAseq.g17517.t1;Pocillopora_acuta_HIv2___RNAseq.g17519.t1;Pocillopora_acuta_HIv2___RNAseq.g19085.t1;Pocillopora_acuta_HIv2___RNAseq.g21032.t1;Pocillopora_acuta_HIv2___RNAseq.g22527.t1;Pocillopora_acuta_HIv2___RNAseq.g23178.t1;Pocillopora_acuta_HIv2___RNAseq.g23210.t1;Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g25351.t1;Pocillopora_acuta_HIv2___RNAseq.g27031.t1;Pocillopora_acuta_HIv2___RNAseq.g2716.t1;Pocillopora_acuta_HIv2___RNAseq.g28109.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28502.t1;Pocillopora_acuta_HIv2___RNAseq.g28504.t1;Pocillopora_acuta_HIv2___RNAseq.g28800.t1;Pocillopora_acuta_HIv2___RNAseq.g28818.t1;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___RNAseq.g28911.t1;Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___RNAseq.g30322.t1;Pocillopora_acuta_HIv2___RNAseq.g30806.t1;Pocillopora_acuta_HIv2___RNAseq.g3515.t1;Pocillopora_acuta_HIv2___RNAseq.g3780.t1;Pocillopora_acuta_HIv2___RNAseq.g3826.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___RNAseq.g9049.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g12453.t2;Pocillopora_acuta_HIv2___TS.g1462.t1;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g23602.t1;Pocillopora_acuta_HIv2___TS.g23673.t1;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g4835.t2;Pocillopora_acuta_HIv2___TS.g5115.t2;Pocillopora_acuta_HIv2___TS.g5308.t2;Pocillopora_acuta_HIv2___TS.g5338.t1;Pocillopora_acuta_HIv2___TS.g8258.t1","Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain];Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain];Hemicentin-1 (Fibulin-6) (FIBL-6);Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);Maternal embryonic leucine zipper kinase (MELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase);Protocadherin Fat 3 (FAT tumor suppressor homolog 3);SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein);Mucin-like protein;Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Mucin-like protein;Hemicentin-1 (Fibulin-6) (FIBL-6);Fibrillin-2 [Cleaved into: Placensin];Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain);Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Halomucin;Protein naked cuticle homolog 2-like (Naked-2-like) (Protein naked cuticle homolog 2-B) (Naked-2B);Tolloid-like protein 1 (EC 3.4.24.-) (Chicken tolloid-like protein 1) (Metalloprotease colloid);Hemicentin-2;Hemicentin-2;Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Mammalian ependymin-related protein 1 (MERP-1);Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2);Plastin-3 (T-plastin);Fibulin-2 (FIBL-2);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Mucin-like protein;Matrilin-4 (MAT-4);Matrilin-3;Synaptotagmin-10 (Synaptotagmin X) (SytX);Matrilin-2;Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide];Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain];Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4);Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein) (Eps15R);Protein kinase C-binding protein NELL1 (NEL-like protein 1);Testican-2 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2);Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Hemicentin-1 (Fibulin-6) (FIBL-6);Protein jagged-1 (Jagged1) (CD antigen CD339);Hemicentin-1 (Fibulin-6) (FIBL-6);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Allograft inflammatory factor 1 (AIF-1) (Ionized calcium-binding adapter molecule 1) (Protein G1);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Matrilin-2;Fibrillin-1 (MP340) [Cleaved into: Asprosin];Hemicentin-1 (Fibulin-6) (FIBL-6);Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Signal peptide, CUB and EGF-like domain-containing protein 3;Hemicentin-2;Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Microtubule-actin cross-linking factor 1, isoforms 6/7 (Uncharacterized protein KIAA0754);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13);Hemicentin-2","Cluster 4: binding"
"27","4",6.39,"GO:0005507","copper ion binding","Binding to a copper (Cu) ion.","10.204% (5/49)",0.33127,0.48,NA,NA,"16.327% (8/49)",0.0003364439,3.47,"Pocillopora_acuta_HIv2___RNAseq.g13784.t1;Pocillopora_acuta_HIv2___RNAseq.g21518.t1;Pocillopora_acuta_HIv2___RNAseq.g2165.t1;Pocillopora_acuta_HIv2___RNAseq.g22559.t1;Pocillopora_acuta_HIv2___RNAseq.g27566.t1;Pocillopora_acuta_HIv2___RNAseq.g30215.t1;Pocillopora_acuta_HIv2___RNAseq.g4785.t1;Pocillopora_acuta_HIv2___RNAseq.g4791.t1","Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase);Diamine oxidase [copper-containing] (Diamine oxidase) (EC 1.4.3.22) (Amine oxidase copper domain-containing protein 1) (Histaminase);DBH-like monooxygenase protein 1 (EC 1.14.17.-) (DBH-related protein) (Monooxygenase X);Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain];Hephaestin-like protein (EC 1.-.-.-);Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain];Coagulation factor VIII (Procoagulant component);Coagulation factor VIII (Procoagulant component)","Cluster 4: binding"
"28","4",5.7,"GO:0005539","glycosaminoglycan binding","Binding to a glycan (polysaccharide) containing a substantial proportion of aminomonosaccharide residues.","8.163% (8/98)",0.4953746,0.31,NA,NA,"15.306% (15/98)",0.001076362,2.97,"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.g10385.t1;Pocillopora_acuta_HIv2___RNAseq.g10557.t1;Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g21518.t1;Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___RNAseq.g3826.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___TS.g1462.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g5006.t1b;Pocillopora_acuta_HIv2___TS.g5115.t2","Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5);Fibroblast growth factor receptor-like 1;SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Diamine oxidase [copper-containing] (Diamine oxidase) (EC 1.4.3.22) (Amine oxidase copper domain-containing protein 1) (Histaminase);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Testican-2 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Fibrillin-1 (MP340) [Cleaved into: Asprosin];Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)","Cluster 4: binding"
"29","4",5.99,"GO:0008201","heparin binding","Binding to heparin, a member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.","9.333% (7/75)",0.363977,0.44,NA,NA,"13.333% (10/75)",0.0003480985,3.46,"Pocillopora_acuta_HIv2___RNAseq.g10385.t1;Pocillopora_acuta_HIv2___RNAseq.g10557.t1;Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g21518.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___TS.g1462.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b","Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5);Fibroblast growth factor receptor-like 1;SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Diamine oxidase [copper-containing] (Diamine oxidase) (EC 1.4.3.22) (Amine oxidase copper domain-containing protein 1) (Histaminase);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Fibrillin-1 (MP340) [Cleaved into: Asprosin];Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)","Cluster 4: binding"
"30","4",8.36,"GO:0042806","fucose binding","Binding to fucose, the pentose 6-deoxygalactose.","71.429% (5/7)",5.123658e-05,4.29,"Pocillopora_acuta_HIv2___RNAseq.g12286.t1;Pocillopora_acuta_HIv2___RNAseq.g12290.t1;Pocillopora_acuta_HIv2___RNAseq.g12292.t1;Pocillopora_acuta_HIv2___RNAseq.g28858.t1;Pocillopora_acuta_HIv2___TS.g3256.t1","Fucolectin-4;Fucolectin;Fucolectin;Collectin-11 (Collectin kidney protein 1) (CL-K1);Fucolectin-3","0% (0/7)",1,0,NA,NA,"Cluster 4: binding"
"31","4",8,"GO:0043208","glycosphingolipid binding","Binding to glycosphingolipid, a compound with residues of sphingoid and at least one monosaccharide.","0% (0/6)",1,0,NA,NA,"50% (3/6)",0.0008697475,3.06,"Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g25351.t1;Pocillopora_acuta_HIv2___TS.g17199.t1","Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Mammalian ependymin-related protein 1 (MERP-1);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha)","Cluster 4: binding"
"32","4",6.75,"GO:0005544","calcium-dependent phospholipid binding","Binding to a phospholipid, a class of lipids containing phosphoric acid as a mono- or diester, in the presence of calcium.","22.857% (8/35)",0.004545858,2.34,"Pocillopora_acuta_HIv2___RNAseq.30415_t;Pocillopora_acuta_HIv2___RNAseq.g13403.t1;Pocillopora_acuta_HIv2___RNAseq.g24760.t1;Pocillopora_acuta_HIv2___RNAseq.g24761.t1;Pocillopora_acuta_HIv2___RNAseq.g2827.t1;Pocillopora_acuta_HIv2___RNAseq.g28815.t1;Pocillopora_acuta_HIv2___RNAseq.g4028.t1;Pocillopora_acuta_HIv2___RNAseq.g4031.t1c","Synaptotagmin-10 (Synaptotagmin X) (SytX);Synaptotagmin-9 (Synaptotagmin IX) (SytIX);Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)];Annexin A6 (Annexin VI) (Annexin-6);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synaptotagmin-1 (Synaptotagmin I) (SytI);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synaptotagmin-1 (Synaptotagmin I) (SytI)","5.714% (2/35)",0.3639029,0.44,NA,NA,"Cluster 4: binding"
"33","4",6.62,"GO:0050840","extracellular matrix binding","Binding to a component of the extracellular matrix.","5.128% (2/39)",0.817508,0.09,NA,NA,"15.385% (6/39)",0.002570167,2.59,"Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g28109.t1;Pocillopora_acuta_HIv2___RNAseq.g29795.t1;Pocillopora_acuta_HIv2___RNAseq.g3826.t1;Pocillopora_acuta_HIv2___TS.g10825.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a","SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Fibulin-2 (FIBL-2);Zonadhesin;Testican-2 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2);Thrombospondin type-1 domain-containing protein 1 (Transmembrane molecule with thrombospondin module);Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment]","Cluster 4: binding"
"34","5",7.67,"GO:0008046","axon guidance receptor activity","Combining with an extracellular messenger and transmitting the signal from one side of the membrane to the other to results in a change in cellular activity involved in axon guidance.","7.143% (1/14)",0.6777618,0.17,NA,NA,"35.714% (5/14)",9.272081e-05,4.03,"Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g8258.t1","Roundabout homolog 2;Roundabout homolog 2;Roundabout homolog 1;Hemicentin-2;Hemicentin-2","Cluster 5: signaling receptor activity"
"35","5",7.82,"GO:0016917","GABA receptor activity","Combining with gamma-aminobutyric acid (GABA), and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. (GABA, 4-aminobutyrate) is an amino acid which acts as a neurotransmitter in some organisms.","41.667% (5/12)",0.001389783,2.86,"Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g2519.t1;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___TS.g305.t1","Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)","0% (0/12)",1,0,NA,NA,"Cluster 5: signaling receptor activity"
"36","5",4.45,"GO:0004930","G protein-coupled receptor activity","Combining with an extracellular signal and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.","13.187% (36/273)",0.001131346,2.95,"Pocillopora_acuta_HIv2___RNAseq.18788_t;Pocillopora_acuta_HIv2___RNAseq.g10339.t1;Pocillopora_acuta_HIv2___RNAseq.g1102.t1;Pocillopora_acuta_HIv2___RNAseq.g11214.t1;Pocillopora_acuta_HIv2___RNAseq.g11547.t1;Pocillopora_acuta_HIv2___RNAseq.g11548.t1;Pocillopora_acuta_HIv2___RNAseq.g1217.t1;Pocillopora_acuta_HIv2___RNAseq.g13056.t1;Pocillopora_acuta_HIv2___RNAseq.g14013.t1a;Pocillopora_acuta_HIv2___RNAseq.g14576.t1;Pocillopora_acuta_HIv2___RNAseq.g14869.t1;Pocillopora_acuta_HIv2___RNAseq.g14871.t1;Pocillopora_acuta_HIv2___RNAseq.g17965.t1;Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g21169.t1;Pocillopora_acuta_HIv2___RNAseq.g22296.t1;Pocillopora_acuta_HIv2___RNAseq.g22964.t1;Pocillopora_acuta_HIv2___RNAseq.g23414.t1;Pocillopora_acuta_HIv2___RNAseq.g2519.t1;Pocillopora_acuta_HIv2___RNAseq.g25689.t1;Pocillopora_acuta_HIv2___RNAseq.g26058.t1;Pocillopora_acuta_HIv2___RNAseq.g28213.t1;Pocillopora_acuta_HIv2___RNAseq.g2915.t1;Pocillopora_acuta_HIv2___RNAseq.g30398.t1;Pocillopora_acuta_HIv2___RNAseq.g3166.t1;Pocillopora_acuta_HIv2___RNAseq.g3723.t1;Pocillopora_acuta_HIv2___RNAseq.g3854.t1;Pocillopora_acuta_HIv2___RNAseq.g6366.t1;Pocillopora_acuta_HIv2___RNAseq.g6379.t1;Pocillopora_acuta_HIv2___RNAseq.g6468.t1;Pocillopora_acuta_HIv2___RNAseq.g8890.t1;Pocillopora_acuta_HIv2___RNAseq.g9811.t1;Pocillopora_acuta_HIv2___TS.g1253.t1;Pocillopora_acuta_HIv2___TS.g17699.t2;Pocillopora_acuta_HIv2___TS.g2952.t1;Pocillopora_acuta_HIv2___TS.g305.t1","Metabotropic glutamate receptor 3 (mGluR3);Adenosine receptor A2b;Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor);Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I);Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155);Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155);Adenosine receptor A2a;Dopamine receptor 4;Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor) (x-BETA1AR);G-protein coupled receptor GRL101;Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor);Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR);Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor);Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2);BTB/POZ domain-containing protein KCTD16;Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)];5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (Serotonin receptor 1B);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20);Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor);Rhodopsin, GQ-coupled (GQ-rhodopsin);QRFP-like peptide receptor;Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2);Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155);Rhodopsin;Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)];Tachykinin-like peptides receptor 86C (NKD);Adhesion G protein-coupled receptor L4;Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)];Adenosine receptor A2a;Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor);Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor);Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (MAR1);Leucine-rich repeat-containing G-protein coupled receptor 6;Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)];Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)","5.495% (15/273)",0.07124894,1.15,NA,NA,"Cluster 5: signaling receptor activity"
"37","5",3.52,"GO:0038023","signaling receptor activity","Receiving a signal and transmitting it in the cell to initiate a change in cell activity. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response.","12.625% (76/602)",0.1077694,0.97,NA,NA,"6.977% (42/602)",0.004405454,2.36,"Pocillopora_acuta_HIv2___RNAseq.g10378.t1;Pocillopora_acuta_HIv2___RNAseq.g10385.t1;Pocillopora_acuta_HIv2___RNAseq.g10557.t1;Pocillopora_acuta_HIv2___RNAseq.g10855.t1;Pocillopora_acuta_HIv2___RNAseq.g12088.t1;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g12306.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g15948.t1;Pocillopora_acuta_HIv2___RNAseq.g15953.t1;Pocillopora_acuta_HIv2___RNAseq.g16484.t1;Pocillopora_acuta_HIv2___RNAseq.g17517.t1;Pocillopora_acuta_HIv2___RNAseq.g17519.t1;Pocillopora_acuta_HIv2___RNAseq.g24196.t1;Pocillopora_acuta_HIv2___RNAseq.g24413.t1;Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g26057.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g30377.t2;Pocillopora_acuta_HIv2___RNAseq.g3094.t1;Pocillopora_acuta_HIv2___RNAseq.g4073.t1;Pocillopora_acuta_HIv2___RNAseq.g434.t1;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g775.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___RNAseq.g8670.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g13017.t1;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g28528.t1a;Pocillopora_acuta_HIv2___TS.g28528.t1b;Pocillopora_acuta_HIv2___TS.g5006.t1b;Pocillopora_acuta_HIv2___TS.g5308.t2;Pocillopora_acuta_HIv2___TS.g5618.t1;Pocillopora_acuta_HIv2___TS.g8131.t1;Pocillopora_acuta_HIv2___TS.g8258.t1","Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206);Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5);Fibroblast growth factor receptor-like 1;Adrenocorticotropic hormone receptor (ACTH receptor) (ACTH-R) (Adrenocorticotropin receptor) (Melanocortin receptor 2) (MC2-R);Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor);Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)];Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Trace amine-associated receptor 1 (TaR-1) (Trace amine receptor 1);Trace amine-associated receptor 1 (TaR-1) (Trace amine receptor 1);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Adrenocorticotropic hormone receptor (ACTH receptor) (ACTH-R) (Adrenocorticotropin receptor) (Melanocortin receptor 2) (MC2-R);Toll-like receptor 2 (CD antigen CD282);Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Roundabout homolog 2;Rhodopsin, GQ-coupled (GQ-rhodopsin);Melatonin receptor type 1C (Mel-1C-R) (Mel1c receptor) (CKB);Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I);Frizzled-5 (Fz-5) (Xfz5);Roundabout homolog 2;Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Roundabout homolog 1;Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Riboflavin-binding protein (RBP) [Cleaved into: Riboflavin-binding protein, plasma form; Riboflavin-binding protein, yolk major form; Riboflavin-binding protein, yolk minor form];Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Aryl hydrocarbon receptor (Ah receptor) (AhR);Hemicentin-2;C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280);Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Tyrosine kinase receptor CEK2);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein);Metabotropic glycine receptor (mGlyR) (G-protein coupled receptor 158);Hemicentin-2","Cluster 5: signaling receptor activity"
"38","6",8.51,"GO:0043028","cysteine-type endopeptidase regulator activity involved in apoptotic process","Binds to and modulates the activity of a cysteine-type endopeptidase involved in the apoptotic process.","50% (3/6)",0.007802079,2.11,"Pocillopora_acuta_HIv2___RNAseq.g18501.t1;Pocillopora_acuta_HIv2___RNAseq.g3051.t1;Pocillopora_acuta_HIv2___RNAseq.g8690.t1","Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2) (hIAP-2) (hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2);Villin-1;Forkhead box protein L2","0% (0/6)",1,0,NA,NA,"Cluster 6: molecular_function"
"39","6",6.23,"GO:0004866","endopeptidase inhibitor activity","Binds to and stops, prevents or reduces the activity of an endopeptidase.","7.692% (4/52)",0.5825748,0.23,NA,NA,"19.231% (10/52)",0.0008855815,3.05,"Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g12378.t1;Pocillopora_acuta_HIv2___RNAseq.g24766.t1;Pocillopora_acuta_HIv2___RNAseq.g28195.t1;Pocillopora_acuta_HIv2___RNAseq.g30027.t1;Pocillopora_acuta_HIv2___RNAseq.g31347.t1;Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g8922.t1;Pocillopora_acuta_HIv2___TS.g23133.t3;Pocillopora_acuta_HIv2___TS.g23144.t1","Tissue inhibitor of metalloproteinase;Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1) (TIMP-1);Papilin;Serine protease inhibitor dipetalogastin (Dipetalin);Metalloproteinase inhibitor 4 (Tissue inhibitor of metalloproteinases 4) (TIMP-4);Equistatin (EI) (Cysteine proteinase inhibitor);Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b (Complement C3b-alpha' chain); Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3b (Complement C3b-alpha' chain)];Pregnancy zone protein (Alpha-2-macroglobulin) (Alpha-2-M) [Cleaved into: Alpha-2-macroglobulin 165 kDa subunit; Alpha-2-macroglobulin 35 kDa subunit];Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3b (Complement C3b-alpha' chain)]","Cluster 6: molecular_function"
"40","6",8.23,"GO:0008191","metalloendopeptidase inhibitor activity","Binds to and stops, prevents or reduces the activity of metalloendopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain and contain a chelated metal ion at their active sites which is essential to their catalytic activity.","12.5% (1/8)",0.4763334,0.32,NA,NA,"37.5% (3/8)",0.002306618,2.64,"Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g12378.t1;Pocillopora_acuta_HIv2___RNAseq.g30027.t1","Tissue inhibitor of metalloproteinase;Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1) (TIMP-1);Metalloproteinase inhibitor 4 (Tissue inhibitor of metalloproteinases 4) (TIMP-4)","Cluster 6: molecular_function"
"41","6",5.84,"GO:0005201","extracellular matrix structural constituent","The action of a molecule that contributes to the structural integrity of the extracellular matrix.","12.941% (11/85)",0.06365222,1.2,NA,NA,"30.588% (26/85)",6.117913e-13,12.21,"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g24766.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___RNAseq.g28911.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___TS.g12846.t1;Pocillopora_acuta_HIv2___TS.g1340.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g1359.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g1462.t1;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g24066.t1","Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Papilin;Collagen alpha-2(I) chain (Alpha-2 type I collagen);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Matrilin-2;Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide];Hemicentin-1 (Fibulin-6) (FIBL-6);Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha chain;Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Fibrillin-1 (MP340) [Cleaved into: Asprosin];Hemicentin-1 (Fibulin-6) (FIBL-6);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Collagen alpha-1(XXVII) chain B;Collagen alpha-2(IV) chain","Cluster 6: molecular_function"
"42","6",7.01,"GO:0030020","extracellular matrix structural constituent conferring tensile strength","A constituent of the extracellular matrix that enables the matrix to resist longitudinal stress.","3.704% (1/27)",0.8875971,0.05,NA,NA,"29.63% (8/27)",3.322178e-06,5.48,"Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g12846.t1;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g23178.t1","Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-1(XXVII) chain B","Cluster 6: molecular_function"
"43","7",8.23,"GO:0004499","N,N-dimethylaniline monooxygenase activity","Catalysis of the reaction: N,N-dimethylaniline + NADPH + H+ + O2 = N,N-dimethylaniline N-oxide + NADP+ + H2O.","12.5% (1/8)",0.4763334,0.32,NA,NA,"37.5% (3/8)",0.002306618,2.64,"Pocillopora_acuta_HIv2___RNAseq.20930_t;Pocillopora_acuta_HIv2___RNAseq.g8978.t1;Pocillopora_acuta_HIv2___RNAseq.g8980.t1","Trimethylamine monooxygenase (TMA monooxygenase) (Tmm) (EC 1.14.13.148);Trimethylamine monooxygenase (TMA monooxygenase) (Tmm) (EC 1.14.13.148);Trimethylamine monooxygenase (TMA monooxygenase) (Tmm) (EC 1.14.13.148)","Cluster 7: catalytic activity"
"44","7",8.51,"GO:0034899","trimethylamine monooxygenase activity","Catalysis of the reaction: N,N,N-trimethylamine + NADPH + H+ + O2 = N,N,N-trimethylamine N-oxide + NADP+ + H2O.","16.667% (1/6)",0.3843764,0.42,NA,NA,"50% (3/6)",0.0008697475,3.06,"Pocillopora_acuta_HIv2___RNAseq.20930_t;Pocillopora_acuta_HIv2___RNAseq.g8978.t1;Pocillopora_acuta_HIv2___RNAseq.g8980.t1","Trimethylamine monooxygenase (TMA monooxygenase) (Tmm) (EC 1.14.13.148);Trimethylamine monooxygenase (TMA monooxygenase) (Tmm) (EC 1.14.13.148);Trimethylamine monooxygenase (TMA monooxygenase) (Tmm) (EC 1.14.13.148)","Cluster 7: catalytic activity"
"45","6",8.51,"GO:0004111","creatine kinase activity","Catalysis of the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H+.","66.667% (4/6)",0.0004763373,3.32,"Pocillopora_acuta_HIv2___RNAseq.g15574.t1;Pocillopora_acuta_HIv2___RNAseq.g15577.t1;Pocillopora_acuta_HIv2___RNAseq.g15584.t1;Pocillopora_acuta_HIv2___RNAseq.g2258.t1","Creatine kinase, testis isozyme (EC 2.7.3.2);Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK);Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK);Arginine kinase (AK) (EC 2.7.3.3)","0% (0/6)",1,0,NA,NA,"Cluster 6: molecular_function"
"46","6",6.9,"GO:0005007","fibroblast growth factor receptor activity","Combining with a fibroblast growth factor receptor ligand and transmitting the signal across the plasma membrane to initiate a change in cell activity.","6.667% (2/30)",0.6885152,0.16,NA,NA,"16.667% (5/30)",0.004097575,2.39,"Pocillopora_acuta_HIv2___RNAseq.g10385.t1;Pocillopora_acuta_HIv2___RNAseq.g10557.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___TS.g28528.t1b;Pocillopora_acuta_HIv2___TS.g5006.t1b","Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5);Fibroblast growth factor receptor-like 1;Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Tyrosine kinase receptor CEK2);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)","Cluster 6: molecular_function"
"47","6",6.81,"GO:0016831","carboxy-lyase activity","Catalysis of the nonhydrolytic addition or removal of a carboxyl group to or from a compound.","23.333% (7/30)",0.006930701,2.16,"Pocillopora_acuta_HIv2___RNAseq.g10736.t1;Pocillopora_acuta_HIv2___RNAseq.g10739.t1;Pocillopora_acuta_HIv2___RNAseq.g11785.t1;Pocillopora_acuta_HIv2___RNAseq.g25727.t1;Pocillopora_acuta_HIv2___RNAseq.g26474.t1a;Pocillopora_acuta_HIv2___RNAseq.g28641.t1;Pocillopora_acuta_HIv2___RNAseq.g29828.t1","Decarboxylase iboD (EC 4.1.1.-) (Ibotenic acid biosynthesis cluster protein D);Decarboxylase iboD (EC 4.1.1.-) (Ibotenic acid biosynthesis cluster protein D);S-adenosylmethionine decarboxylase proenzyme (AdoMetDC) (SAMDC) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase alpha chain; S-adenosylmethionine decarboxylase beta chain];Phosphonopyruvate decarboxylase (PnPy decarboxylase) (EC 4.1.1.82);Ornithine decarboxylase (ODC) (EC 4.1.1.17);Protein TabA;L-tyrosine decarboxylase (TDC) (EC 4.1.1.25)","0% (0/30)",1,0,NA,NA,"Cluster 6: molecular_function"
"48","6",8.11,"GO:0004062","aryl sulfotransferase activity","Catalysis of the reaction: 3'-phosphoadenosine 5'-phosphosulfate + a phenol = adenosine 3',5'-bisphosphate + an aryl sulfate.","66.667% (6/9)",1.471337e-05,4.83,"Pocillopora_acuta_HIv2___RNAseq.10969_t;Pocillopora_acuta_HIv2___RNAseq.g12481.t1;Pocillopora_acuta_HIv2___RNAseq.g21538.t1;Pocillopora_acuta_HIv2___RNAseq.g9089.t1;Pocillopora_acuta_HIv2___RNAseq.g9090.t1;Pocillopora_acuta_HIv2___RNAseq.g9093.t1","Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase);Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1);Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase);Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1);Sulfotransferase 1C2A (ST1C2A) (rSULT1C2A) (EC 2.8.2.1) (Sulfotransferase K2);Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1) (Sulfotransferase 1C2) (SULT1C#2)","0% (0/9)",1,0,NA,NA,"Cluster 6: molecular_function"
"49","6",8.51,"GO:0008859","exoribonuclease II activity","Catalysis of the reaction: RNA + H2O = 5'-phosphomononucleotides. Cleaves RNA in the 3' to 5' direction.","50% (3/6)",0.007802079,2.11,"Pocillopora_acuta_HIv2___RNAseq.g7644.t1;Pocillopora_acuta_HIv2___RNAseq.g7645.t1;Pocillopora_acuta_HIv2___RNAseq.g9789.t1","3'-5' exoribonuclease HELZ2 (EC 3.1.13.1) (ATP-dependent RNA helicase PRIC285) (EC 3.6.4.13) (Helicase with zinc finger 2, transcriptional coactivator) (Helicase with zinc finger domain 2) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein);3'-5' exoribonuclease HELZ2 (EC 3.1.13.1) (ATP-dependent RNA helicase PRIC285) (EC 3.6.4.13) (Helicase with zinc finger 2, transcriptional coactivator) (Helicase with zinc finger domain 2) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein);DIS3-like exonuclease 1 (EC 3.1.13.1)","0% (0/6)",1,0,NA,NA,"Cluster 6: molecular_function"
"50","6",4.37,"GO:0000981","DNA-binding transcription factor activity, RNA polymerase II-specific","A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II.","11.786% (33/280)",0.01019067,1.99,NA,NA,"6.786% (19/280)",0.006352596,2.2,"Pocillopora_acuta_HIv2___RNAseq.10616_t;Pocillopora_acuta_HIv2___RNAseq.g14750.t1;Pocillopora_acuta_HIv2___RNAseq.g15510.t1;Pocillopora_acuta_HIv2___RNAseq.g17573.t1;Pocillopora_acuta_HIv2___RNAseq.g1763.t1;Pocillopora_acuta_HIv2___RNAseq.g21418.t1;Pocillopora_acuta_HIv2___RNAseq.g29895.t1;Pocillopora_acuta_HIv2___RNAseq.g30675.t1;Pocillopora_acuta_HIv2___RNAseq.g3832.t1;Pocillopora_acuta_HIv2___RNAseq.g5138.t1;Pocillopora_acuta_HIv2___RNAseq.g614.t1;Pocillopora_acuta_HIv2___RNAseq.g6737.t1;Pocillopora_acuta_HIv2___RNAseq.g7509.t2;Pocillopora_acuta_HIv2___RNAseq.g8062.t1;Pocillopora_acuta_HIv2___RNAseq.g942.t1;Pocillopora_acuta_HIv2___RNAseq.g9588.t1;Pocillopora_acuta_HIv2___RNAseq.g9589.t2;Pocillopora_acuta_HIv2___TS.7324_t;Pocillopora_acuta_HIv2___TS.g13017.t1","Transcription factor MBS1 (Mbp1/Swi4-like protein 1);Krueppel-like factor 13 (Basic transcription element-binding protein 3) (BTE-binding protein 3) (Novel Sp1-like zinc finger transcription factor 1) (RANTES factor of late activated T-lymphocytes 1) (RFLAT-1) (Transcription factor BTEB3) (Transcription factor NSLP1);Hepatocyte nuclear factor 3-beta (HNF-3-beta) (HNF-3B) (Forkhead box protein A2) (Me-HNF3B);Homeobox protein Hox-D1;Homeobox protein aristaless-like 4;POU domain protein CF1A (Chorion factor 1A) (CF1-A) (Protein drifter) (Ventral veins lacking protein);Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND);Fork head domain-containing protein FD5;Diencephalon/mesencephalon homeobox protein 1-B;Iroquois-class homeodomain protein irx-4-A (Iroquois homeobox protein 4-A);Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3);ETS domain-containing protein Elk-1;Myelin regulatory factor (EC 3.4.-.-) (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal];Forkhead box protein C2-B (FoxC2-B) (FoxC2b) (Fork head domain-related protein 4') (FD-4') (xFD-4') (xFD4 B);Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A);Homeobox protein otx5-B (Orthodenticle homolog 5-B) (XOtx5b);Homeobox protein OTX1 B (zOtx1) (Orthodenticle homolog 1 B);Homeobox protein koza (Homeodomain transcription factor koza);Aryl hydrocarbon receptor (Ah receptor) (AhR)","Cluster 6: molecular_function"
"51","7",7.91,"GO:0005001","transmembrane receptor protein tyrosine phosphatase activity","Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate.","45.455% (5/11)",0.0008657117,3.06,"Pocillopora_acuta_HIv2___RNAseq.g12287.t1;Pocillopora_acuta_HIv2___RNAseq.g12289.t1;Pocillopora_acuta_HIv2___RNAseq.g12293.t1;Pocillopora_acuta_HIv2___RNAseq.g9334.t1;Pocillopora_acuta_HIv2___TS.g1768.t1","Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)","9.091% (1/11)",0.3338988,0.48,NA,NA,"Cluster 7: catalytic activity"
"52","7",5.94,"GO:0004725","protein tyrosine phosphatase activity","Catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate.","9.677% (6/62)",0.9835743,0.01,NA,NA,"11.29% (7/62)",0.006847494,2.16,"Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g12272.t1;Pocillopora_acuta_HIv2___RNAseq.g12278.t1;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1","Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","Cluster 7: catalytic activity"
"53","7",6.1,"GO:0004252","serine-type endopeptidase activity","Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).","5.97% (4/67)",0.7747279,0.11,NA,NA,"19.403% (13/67)",6.368537e-07,6.2,"Pocillopora_acuta_HIv2___RNAseq.21012_t;Pocillopora_acuta_HIv2___RNAseq.21015_t;Pocillopora_acuta_HIv2___RNAseq.g13818.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g21967.t1;Pocillopora_acuta_HIv2___RNAseq.g28450.t1;Pocillopora_acuta_HIv2___RNAseq.g30322.t1;Pocillopora_acuta_HIv2___RNAseq.g8820.t1;Pocillopora_acuta_HIv2___RNAseq.g9068.t1;Pocillopora_acuta_HIv2___RNAseq.g9084.t1;Pocillopora_acuta_HIv2___RNAseq.g9098.t1;Pocillopora_acuta_HIv2___TS.g5338.t1;Pocillopora_acuta_HIv2___TS.g7062.t1","Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain];Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain];Serine protease 23 (EC 3.4.21.-) (Putative secreted protein Zsig13);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)];Trypsin-3 (EC 3.4.21.4) (Trypsin III);Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain];Complement C2 (C3/C5 convertase) [Cleaved into: Complement C2a; Serine protease complement C2b (EC 3.4.21.43)];Complement factor B (EC 3.4.21.47) (C3/C5 convertase) [Cleaved into: Complement factor B Ba; Complement factor B Bb];Complement C2 (C3/C5 convertase) [Cleaved into: Complement C2a; Serine protease complement C2b (EC 3.4.21.43)];Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain];Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13);Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","Cluster 7: catalytic activity"
"54","7",5.57,"GO:0004222","metalloendopeptidase activity","Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.","10% (11/110)",0.2334336,0.63,NA,NA,"9.091% (10/110)",0.006459289,2.19,"Pocillopora_acuta_HIv2___RNAseq.g22527.t1;Pocillopora_acuta_HIv2___RNAseq.g22572.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g24899.t1;Pocillopora_acuta_HIv2___RNAseq.g30235.t1;Pocillopora_acuta_HIv2___RNAseq.g8587.t1;Pocillopora_acuta_HIv2___RNAseq.g9118.t1;Pocillopora_acuta_HIv2___TS.g13882.t1c;Pocillopora_acuta_HIv2___TS.g5338.t1;Pocillopora_acuta_HIv2___TS.g8967.t1","Tolloid-like protein 1 (EC 3.4.24.-) (Chicken tolloid-like protein 1) (Metalloprotease colloid);Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15);Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP);Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15);Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14);Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A);Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13);Extracellular protease (EC 3.4.24.-)","Cluster 7: catalytic activity"
